Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 17, 2023

SELL
$162.42 - $220.56 $308,598 - $419,064
-1,900 Reduced 26.39%
5,300 $897 Million
Q3 2022

May 16, 2023

SELL
$160.42 - $256.21 $128,335 - $204,967
-800 Reduced 10.0%
7,200 $1.35 Billion
Q1 2022

Apr 21, 2022

BUY
$161.19 - $257.96 $225,666 - $361,144
1,400 Added 21.21%
8,000 $1.51 Million
Q4 2021

Feb 03, 2022

BUY
$247.59 - $304.47 $74,277 - $91,341
300 Added 4.76%
6,600 $1.75 Million
Q3 2021

Oct 21, 2021

BUY
$194.77 - $324.21 $116,862 - $194,526
600 Added 10.53%
6,300 $1.82 Million
Q1 2021

Apr 30, 2021

SELL
$180.37 - $226.26 $360,740 - $452,520
-2,000 Reduced 25.97%
5,700 $1.11 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $118,464 - $165,256
-800 Reduced 9.41%
7,700 $1.48 Million
Q3 2020

Nov 12, 2020

BUY
$122.51 - $158.27 $563,546 - $728,042
4,600 Added 117.95%
8,500 $1.25 Million
Q2 2020

Aug 12, 2020

SELL
$94.33 - $140.48 $1.4 Million - $2.08 Million
-14,800 Reduced 79.14%
3,900 $482,000
Q1 2020

May 12, 2020

SELL
$84.96 - $109.14 $118,943 - $152,796
-1,400 Reduced 6.97%
18,700 $1.81 Million
Q4 2019

Jan 27, 2020

SELL
$73.84 - $93.08 $73,840 - $93,080
-1,000 Reduced 4.74%
20,100 $1.86 Million
Q3 2019

Oct 22, 2019

SELL
$76.65 - $95.51 $206,955 - $257,877
-2,700 Reduced 11.34%
21,100 $1.62 Million
Q2 2019

Jul 26, 2019

SELL
$54.2 - $85.95 $211,380 - $335,205
-3,900 Reduced 14.08%
23,800 $2.05 Million
Q1 2019

Apr 25, 2019

SELL
$49.45 - $62.8 $197,800 - $251,200
-4,000 Reduced 12.62%
27,700 $1.64 Million
Q4 2018

Feb 07, 2019

SELL
$48.26 - $68.88 $719,074 - $1.03 Million
-14,900 Reduced 31.97%
31,700 $1.67 Million
Q3 2018

Nov 02, 2018

SELL
$46.8 - $58.97 $145,080 - $182,807
-3,100 Reduced 6.24%
46,600 $2.58 Million
Q2 2018

Aug 03, 2018

BUY
$35.26 - $47.04 $1.75 Million - $2.34 Million
49,700 New
49,700 $2.34 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.